Document Detail


Vaginal misoprostol administration for cervical ripening and labor induction.
MedLine Citation:
PMID:  16885668     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intravaginal misoprostol has been shown to be an effective agent for cervical ripening and induction of labor. Vaginal application of misoprostol has been reported in over 9000 women worldwide and seems to have safety profile similar to that of endocervically and intravaginally administered dinoprostone. Concern arises with the use of higher doses of intravaginal misoprostol (50 mcg or more) and the association with uterine contractile abnormalities and for this reason, use of low-dose misoprostol regimen has been recommended by the American College of Obstetricians and Gynecologists. The recommendation is use of a 25-mcg dose of misoprostol inserted into the posterior vaginal fornix and repeated every 3 to 6 hours as needed. Misoprostol administration to women with prior cesarean births seems to increase the likelihood of uterine scar disruption and should not be used in these women. There are reports of uterine rupture in women with unscarred uteri treated with vaginally applied misoprostol. Therefore, all patients need to be monitored adequately after misoprostol administration. Although there is a growing body of data regarding the ambulatory use of intravaginal misoprostol for cervical ripening, its use for this purpose cannot be recommended outside of investigational protocols at this time because of concerns for maternal and neonatal safety.
Authors:
Deborah A Wing; Cecilia A Lyons Gaffaney
Related Documents :
2320718 - Congenital malformations, stillbirths, and early mortality among the children of atomic...
12202418 - The kinetics of serum hcg and progesterone in response to oral and vaginal administrati...
12959148 - Early medical termination pregnancy with methotrexate and misoprostol in lower segment ...
12332898 - Intra-amniotic injection of hypertonic solution as a method for termination of pregnancy.
23936698 - Arabin cerclage pessary as a treatment of an acute urinary retention in a pregnant woma...
23105768 - Effect of anti-epileptic drugs in pregnancy and teratogenesis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  49     ISSN:  0009-9201     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-03     Completed Date:  2006-10-27     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  627-41     Citation Subset:  IM    
Affiliation:
Division of Maternal-Fetal Medicine, Department of Obstetrics-Gynecology, University of California, Irvine, School of Medicine, Irvine, California, USA. dwing@uci.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intravaginal
Ambulatory Care
Cervical Ripening / drug effects*
Cesarean Section
Dose-Response Relationship, Drug
Drug Labeling
Female
Fetal Membranes, Premature Rupture / drug therapy
Humans
Labor, Induced / methods*
Misoprostol / administration & dosage*,  adverse effects,  pharmacokinetics
Oxytocics / administration & dosage*,  adverse effects,  pharmacokinetics
Pregnancy
Chemical
Reg. No./Substance:
0/Oxytocics; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Natural prostaglandins for induction of labor and preinduction cervical ripening.
Next Document:  Mechanical methods of cervical ripening and labor induction.